Delivery Order SPE2DB20D1100-SPE2DB25FC4S4
Award Date
5/22/25
Potential Completion Date
5/23/25
Potential Value
$5.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,044.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10,000 units of chorionic gonad, a medical product, with a final completion date of April 29, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $5,134.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 10,000 units of chorionic gonad, a medical product. The contract is not set-aside and is a firm fixed-price arrangement with an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 10,000 units of Chorionic Gonad, a medical product, with a ceiling value of $7,219.13. The contract is a firm fixed-price delivery order with an ultimate completion date of December 26, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,184.77 firm fixed-price delivery order is for the procurement of 10,000 units of Chorionic Gonad, a medical product, with a performance completion date of November 23, 2022. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The $1,199.06 firm fixed-price delivery order (SPE2DB22D1106|SPE2DB25FEGU5) is for the procurement of 10,000 units of CHORIONIC GONAD, with a completion date of April 9, 2025. This award is not associated with a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of 10,000 units of chorionic gonad, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 25, 2024, with a ceiling value of $24,197.44 and a completion date of March 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Chorionic Gonad 10,000 unit vials. The fixed-price delivery order, valued at $8,032.56, was issued by the Defense Logistics Agency (DLA), a defense agency. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 10,000 units of Chorionic Gonad with a potential value of $8,113.20. The contract has a completion date of February 20, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is the prime contractor on this delivery order, which is issued under a larger indefinite...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. This...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML medical products. The contract, valued at $29,713.37, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a firm fixed price delivery order contract type with a completion date of January 23, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...